Disrupting TGF-β signaling in Cspg4-lineage pericytes via genetic deletion of TGF-βR1 improved cardiac function 7 days after MI and showed reduced fibrosis 14 days after MI. The gene discussed is TGFB1; the disease is myocardial infarction.